Want to join the conversation?
$BMY 2Q15 Call: Over next five years, expects growth to come primarily from Opdivo and Eliquis with contribution from the rest of existing portfolio of medicines. Announced today that European Commission validated two Opdivo applications; one for non-squamous cell lung cancer and two in combination with Yervoy for Metastatic Melanoma.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!